BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5924653)

  • 1. Circadian variation of the plasma 17-hydroxycorticosteroids in central nervous system disease.
    Krieger DT; Krieger HP
    J Clin Endocrinol Metab; 1966 Sep; 26(9):929-40. PubMed ID: 5924653
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of organic brain lesions on adrenal cortical activity.
    Krieger DT; Krieger HP
    Res Publ Assoc Res Nerv Ment Dis; 1966; 43():400-18. PubMed ID: 5913618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in plasma ACTH activity by oral administration of SU-4485].
    Hirano T
    Nihon Naibunpi Gakkai Zasshi; 1967 Nov; 43(8):733-45. PubMed ID: 4297222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diurnal variation of plasma cortisol concentration in patients with various diseases and negative feedback mechanism of the pituitary-adrenal axis].
    Hasui K
    Nihon Naibunpi Gakkai Zasshi; 1969 Sep; 45(6):613-34. PubMed ID: 4310447
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Sequential changes during oral and intravenous metyrapone administration.
    Jubiz W; Matsukura S; Meikle AW; Harada G; West CD; Tyler FH
    Arch Intern Med; 1970 Mar; 125(3):468-71. PubMed ID: 4313727
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of serum (and urinary) 17-hydroxycorticosteroids and 17-ketosteroids].
    Iwai K; Honda H
    Nihon Rinsho; 1976; 34 suppl():2112-31. PubMed ID: 186650
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenocortical function in depressive states--study of circadian variation in plasma and urinary steroids.
    Lohrenz FN; Fullerton DT; Fahs H; Wenzel FJ
    Int J Neuropsychiatry; 1968 Feb; 4(1):21-5. PubMed ID: 5645816
    [No Abstract]   [Full Text] [Related]  

  • 8. The hypothalamic-pituitary-adrenal function in children with severe cerebral lesions: an evaluation.
    Faglia G; Manghi E; Ambrosi B; Travaglini P; Norbiato G
    Folia Endocrinol; 1971 Apr; 24(2):94-109. PubMed ID: 4334173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chrono-regulation and function of the hypothalamo-hypophyseal-adrenal system in anorexia nervosa].
    Ferrari E; Bossolo PA; Braschi A; Crosti C
    Folia Endocrinol; 1973 Oct; 26(5):422-34. PubMed ID: 4801009
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma growth hormone response to vasopressin: comparison with saline infusion in normal subjects and with insulin-induced hypoglycaemia in patients with intra- and suprasell tumours.
    Quabbe HJ
    Acta Endocrinol (Copenh); 1970 Feb; 63(2):359-77. PubMed ID: 5468630
    [No Abstract]   [Full Text] [Related]  

  • 11. Circadian rhythm of urinary 17-hydroxycorticosteroids during metyrapone-induced ACTH release in normal subjects.
    Angeli A; Fonzo D; Bertello P; Gaidano G; Ceresa F
    Chronobiologia; 1975; 2(2):133-44. PubMed ID: 172298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma 17-hydroxycorticosteroids (OHCS) and 17-ketosteroids (KS) (including urinary contents): interpretation of the test results in the field of internal medicine].
    Iwai K; Yawata M; Tamura Y; Sako Y; Honda H
    Nihon Rinsho; 1969 Mar; ():Suppl:906-20. PubMed ID: 4948301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Psychic states and diurnal rhythm of plasma 17-hydroxycorticosteroids--a psychophysiological study of emotion].
    Moroji T
    Seishin Shinkeigaku Zasshi; 1966 Dec; 68(12):1443-62. PubMed ID: 6010006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical studies on the adrenocorticotropic hormone. II. Studies on the mechanism of pituitary corticotropin secretion with synthetic lysine vasopressin].
    Mayama T
    Nihon Naibunpi Gakkai Zasshi; 1968 Jan; 43(10):947-56. PubMed ID: 4298936
    [No Abstract]   [Full Text] [Related]  

  • 15. [Circadian variations of 17-hydroxycorticosteroids and of tetrahydro-11-deoxycortisol in the healthy man: effect of the continuous administration of metyrapone (SU 4885)].
    Touitou Y; Bogdan A; Limal JM; Reinberg A
    C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(13):913-5. PubMed ID: 811399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liver disease upon adrenocortical ACTH and metyrapone responsiveness in man.
    Tucci JR; Martin MM
    Gastroenterology; 1966 Oct; 51(4):515-23. PubMed ID: 4288532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Endocrinal disorders of suprahypophyseal origin].
    Ruedi B
    Schweiz Med Wochenschr; 1967 Sep; 97(38):1254-61. PubMed ID: 4298884
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma 17-OHCS and 17-KS (including the urine content--how to read its figures].
    Iwai K; Honda H
    Nihon Rinsho; 1971 Jan; 29():Suppl:432-49. PubMed ID: 4324733
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian rhythms in urinary steroids in response to a 36-hour sustained metyrapone administration in eight young men.
    Touitou Y; Bogdan A; Limal JM; Touitou C; Reinberg A
    Horm Metab Res; 1977 Jul; 9(4):314-21. PubMed ID: 892697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diurnal variation of the plasma level and the urinary excretion of corticoids in normal and disturbed states of consciousness].
    Moroji T; Yamazaki K; Kato H; Onodera I
    Seishin Shinkeigaku Zasshi; 1966 Dec; 68(12):1421-33. PubMed ID: 6010004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.